The overall goal of this project is to understand how the regulation of cell death is used to control immune responses in vivo. The proposed studies take advantage of a gene-targeted mouse train which lacks the alpha chain of the IL-2 receptor. These mice develop a lymphoproliferative disorder and autoimmunity, which correlates with a defect in the ability of T-cells to undergo apoptosis in response to activation. A variety of genes which regulate cell survival and death have been identified, including Fas, which is involved in activation-induced cell death, as well as members of the Bcl-2 family, which may participate in distinct cell survival pathways.
The aims of this application seek to identify the mechanisms of cell death regulation by IL-2R signals in vivo. Experiments are proposed to examine how genes involved in cell death and cell survival (including Fas, Fas ligand, Bcl-2, Bcl-X and Bax) may be regulated differently in lymphocytes from normal and IL-2R alpha deficient mice, and whether the Fas-mediated cell death pathway is functional. In addition, possible synergistic effects of Bcl-2 overexpression and dysregulation of IL-2Ralpha mutation. Finally, a system is proposed to study in detail how the fate of T-cells after antigen stimulation is affected by the IL-2Ralpha mutation. This system will utilize a T-cell receptor transgene introduced into the IL-2R alpha mutant background to facilitate uniform response to a defined antigen. Following immunization, t cell proliferation, cell death and differentiation into memory cells will be studied in detail. Regulation of cell death in the immune system is emerging as a major control point in both development of T- and B-cells and the regulation of the peripheral immune repertoire. The consequences of dysfunctional regulation of these pathways include autoimmunity and lymphoproliferative disorders, and have been implicated in the CD4+ T- cell destruction in HIV infection. Hence these studies are directly relevant to the pathogenesis of autoimmune diseases, lymphoid cancers and AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI041051-06
Application #
6170407
Study Section
Immunobiology Study Section (IMB)
Program Officer
Quill, Helen R
Project Start
1996-07-15
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2002-06-30
Support Year
6
Fiscal Year
2000
Total Cost
$139,880
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Yang, Xuexian O; Doty, Raymond T; Hicks, Justin S et al. (2003) Regulation of T-cell receptor D beta 1 promoter by KLF5 through reiterated GC-rich motifs. Blood 101:4492-9
Chuang, Peter I; Morefield, Samantha; Liu, Chien-Ying et al. (2002) Perturbation of B-cell development in mice overexpressing the Bcl-2 homolog A1. Blood 99:3350-9
Doty, Raymond T; Vanasse, Gary J; Disteche, Christine M et al. (2002) The leukemia-associated gene Mllt1/ENL: characterization of a murine homolog and demonstration of an essential role in embryonic development. Blood Cells Mol Dis 28:407-17
Leung, D T; Morefield, S; Willerford, D M (2000) Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo. J Immunol 164:3527-34
Zheng, L; Trageser, C L; Willerford, D M et al. (1998) T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J Immunol 160:763-9
Nelson, B H; Willerford, D M (1998) Biology of the interleukin-2 receptor. Adv Immunol 70:1-81